lorazepam has been researched along with Depression, Endogenous in 50 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We report a case of severe protracted depression induced by IFN in a patient diagnosed with melanoma who responded rapidly to a course of methylphenidate using the Hamilton Depressive Rating Scale." | 3.73 | Methylphenidate for alpha-interferon induced depression. ( Camacho, A; Ng, B, 2006) |
| "The severity of withdrawal symptoms was measured using the Clinical Institute Withdrawal Assessment-Benzodiazepines (CIWA-B) questionnaire." | 2.71 | Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression. ( Brunner, H; Friess, E; Holsboer, F; Ising, M; Pedrosa Gil, F; Wichniak, A, 2004) |
| "The perceived degree of improvement of insomnia was proportional to the advance in timing of sleep onset obtained with treatment." | 2.71 | Lormetazepam in depressive insomnia: new evidence of phase-response effects of benzodiazepines. ( Benedetti, F; Bernasconi, A; Colombo, C; Florita, M; Pontiggia, A; Smeraldi, E, 2004) |
| "Lorazepam (10 mg/day) was also given to both groups." | 2.66 | Viqualine in resistant depression: a double-blind, placebo-controlled trial. ( Albanesi, G; Faravelli, C; Sessarego, A, 1988) |
| "However, interictal delirium is uncommon in absence of risk factors." | 1.38 | Delayed onset and prolonged interictal delirium following electroconvulsive therapy. ( Praharaj, SK; Selvaraj, AG, 2012) |
| "Catatonia is a well-described neuropsychiatric syndrome that has been the subject of several texts." | 1.37 | Cases of catatonia on an academic electroconvulsive therapy service: lessons to learn. ( Aloysi, AS; Kellner, CH; Popeo, DM, 2011) |
| "We describe an unusual presentation of catatonia in a female patient with schizoaffective disorder." | 1.37 | An unusual presentation of catatonia in a patient with schizoaffective disorder. ( Liang, CS; Liao, WC; Yang, FW, 2011) |
| "Imipramine doses were adjusted to attain a predefined fixed plasma level." | 1.35 | Efficacy of imipramine in psychotic versus nonpsychotic depression. ( Birkenhager, TK; Bruijn, JA; Moleman, P; Mulder, PG; van den Broek, WW, 2008) |
| "Three patients had exceptionally high seizure threshold, as determined by an empirical titration procedure." | 1.29 | Exceptionally high seizure threshold: ECT device limitations. ( Devanand, DP; Lisanby, SH; Mullen, L; Nobler, MS; Prudic, J; Sackeim, HA, 1996) |
| " Caution should be exercised in long-term use of benzodiazepines in susceptible individuals." | 1.27 | Delusional depression following benzodiazepine withdrawal. ( Eales, M; Joyce, E; Keshavan, MS; Moodley, P; Yeragani, VK, 1988) |
| " Her elimination half-life for desipramine was found to be greatly prolonged, at approximately 150 hours." | 1.27 | Idiosyncratic pharmacokinetics complicating treatment of major depression in an elderly woman. ( Dugas, JE; Glassman, JN; Loyd, DW; Tsuang, MT, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (38.00) | 18.7374 |
| 1990's | 13 (26.00) | 18.2507 |
| 2000's | 10 (20.00) | 29.6817 |
| 2010's | 7 (14.00) | 24.3611 |
| 2020's | 1 (2.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uvais, NA | 1 |
| Santos-Cubiñá, J | 1 |
| Torres-Rodríguez, A | 1 |
| Castaing-Lespier, PA | 1 |
| Sabaté, N | 1 |
| Torres-Martin, A | 1 |
| Carlo, S | 1 |
| Prakash, S | 1 |
| Mandal, P | 1 |
| Frank, C | 1 |
| Portilla-Botelho, M | 1 |
| Ortega-Carnicer, J | 1 |
| Gómez-Grande, ML | 1 |
| Martín-Rodríguez, C | 1 |
| Rätz Bravo, AE | 1 |
| Zimmermann, T | 1 |
| Haschke, M | 1 |
| Aloysi, AS | 1 |
| Popeo, DM | 1 |
| Kellner, CH | 1 |
| Liang, CS | 1 |
| Yang, FW | 1 |
| Liao, WC | 1 |
| Jung, JJ | 1 |
| Baek, SH | 1 |
| Kim, US | 1 |
| Selvaraj, AG | 1 |
| Praharaj, SK | 1 |
| Curtin, F | 1 |
| Redmund, C | 1 |
| Wichniak, A | 1 |
| Brunner, H | 1 |
| Ising, M | 1 |
| Pedrosa Gil, F | 1 |
| Holsboer, F | 1 |
| Friess, E | 1 |
| Benedetti, F | 1 |
| Pontiggia, A | 1 |
| Bernasconi, A | 1 |
| Colombo, C | 1 |
| Florita, M | 1 |
| Smeraldi, E | 1 |
| Englert, I | 1 |
| Müller, N | 1 |
| Schwarz, MJ | 1 |
| Dehning, S | 1 |
| Douhe, A | 1 |
| Cerovecki, A | 1 |
| Goldstein-Müller, B | 1 |
| Spellmann, I | 1 |
| Hetzel, G | 1 |
| Maino, K | 1 |
| Kleindienst, N | 1 |
| Möller, HJ | 1 |
| Arolt, V | 1 |
| Riedel, M | 1 |
| Camacho, A | 1 |
| Ng, B | 1 |
| Hammerman, S | 1 |
| Lam, C | 1 |
| Caroff, SN | 1 |
| Birkenhager, TK | 1 |
| van den Broek, WW | 1 |
| Mulder, PG | 1 |
| Moleman, P | 1 |
| Bruijn, JA | 1 |
| Ravenna, C | 1 |
| Zung, WW | 1 |
| Daniel, JT | 1 |
| King, RE | 1 |
| Moore, DT | 1 |
| Fouks, L | 1 |
| Rosenblatt, JE | 1 |
| Widlocher, D | 1 |
| Lecrubier, Y | 1 |
| Le Goc, Y | 1 |
| Olajide, D | 1 |
| Lader, M | 1 |
| Kahan, BB | 1 |
| Haskett, RF | 1 |
| Romach, M | 1 |
| Busto, U | 1 |
| Somer, G | 1 |
| Kaplan, HL | 1 |
| Sellers, E | 1 |
| Ansseau, M | 1 |
| Papart, P | 1 |
| Troisfontaines, B | 1 |
| Bartholomé, F | 1 |
| Bataille, M | 1 |
| Charles, G | 1 |
| Schittecatte, M | 1 |
| Darimont, P | 1 |
| Devoitille, JM | 1 |
| De Wilde, J | 1 |
| Nolen, WA | 2 |
| Haffmans, PM | 1 |
| Bouvy, PF | 2 |
| Duivenvoorden, HJ | 1 |
| Northoff, G | 1 |
| Wenke, J | 1 |
| Demisch, L | 1 |
| Eckert, J | 1 |
| Gille, B | 1 |
| Pflug, B | 1 |
| Lisanby, SH | 1 |
| Devanand, DP | 1 |
| Nobler, MS | 1 |
| Prudic, J | 1 |
| Mullen, L | 1 |
| Sackeim, HA | 1 |
| de Groot, MH | 1 |
| Huijsman, AM | 1 |
| Carroll, BT | 1 |
| Buysse, DJ | 1 |
| Reynolds, CF | 1 |
| Houck, PR | 1 |
| Perel, JM | 1 |
| Frank, E | 1 |
| Begley, AE | 1 |
| Mazumdar, S | 1 |
| Kupfer, DJ | 1 |
| Koek, RJ | 1 |
| Mervis, JR | 1 |
| Sánchez Romero, A | 1 |
| Calzado Solaz, C | 1 |
| Benazzi, F | 1 |
| Laws, D | 1 |
| Ashford, JJ | 1 |
| Anstee, JA | 1 |
| Swerdlow, NR | 1 |
| Gierz, M | 1 |
| Berkowitz, A | 1 |
| Nemiroff, R | 1 |
| Lohr, J | 1 |
| Swartz, CM | 1 |
| Breen, K | 1 |
| Wahby, VS | 1 |
| Lydiard, RB | 1 |
| Howell, EF | 1 |
| Laraia, MT | 1 |
| Fossey, MD | 1 |
| Ballenger, JC | 1 |
| Wetzel, H | 2 |
| Heuser, I | 2 |
| Benkert, O | 2 |
| Newhouse, PA | 1 |
| Sunderland, T | 1 |
| Tariot, PN | 1 |
| Weingartner, H | 1 |
| Thompson, K | 1 |
| Mellow, AM | 1 |
| Cohen, RM | 1 |
| Murphy, DL | 1 |
| Faravelli, C | 1 |
| Albanesi, G | 1 |
| Sessarego, A | 1 |
| Keshavan, MS | 1 |
| Moodley, P | 1 |
| Eales, M | 1 |
| Joyce, E | 1 |
| Yeragani, VK | 1 |
| Pande, AC | 1 |
| Greenfeld, D | 1 |
| Conrad, C | 1 |
| Kincare, P | 1 |
| Bowers, MB | 1 |
| Sandyk, R | 1 |
| Scottez, B | 1 |
| Peutillot, A | 1 |
| Glassman, JN | 1 |
| Dugas, JE | 1 |
| Tsuang, MT | 1 |
| Loyd, DW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of a Sea-safety Course on Mood, Mental Wellbeing and Inflammation[NCT04528485] | 61 participants (Actual) | Interventional | 2020-07-01 | Completed | |||
| Minocycline as an Adjunct for the Treatment of Depressive Symptoms: Pilot Randomized Controlled Trial[NCT02263872] | Phase 4 | 41 participants (Actual) | Interventional | 2014-10-31 | Completed | ||
| Salicylic Augmentation in Depression[NCT03152409] | Phase 2 | 74 participants (Anticipated) | Interventional | 2018-11-15 | Recruiting | ||
| Effect of Bupropion on Seizure Threshold in Depressed Patients[NCT03126682] | Phase 4 | 10 participants (Actual) | Interventional | 2017-08-25 | Completed | ||
| A Randomised Double-Blinded Placebo-Controlled Trial to Assess the Efficacy and Safety of Scopolamine Compared to Placebo in Individuals With Bipolar Disorder Who Are Experiencing a Depressive Episode[NCT04211961] | Phase 2 | 50 participants (Anticipated) | Interventional | 2021-03-23 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Scoring of depressive symptoms on the Montgomery Asberg Depression Rating Scale, maximum 60 , minimum 0. Higher scores mean worse outcome. First measurement on day 1 of electroconvulsive treatment (ECT) and second measurement on day 2 of electroconvulsive therapy (ECT), separated by 1 day interval. This outcome measure was not measured at baseline. (NCT03126682)
Timeframe: Scored on day 1 and day 2 after ECT session
| Intervention | Scored on a scale (Mean) |
|---|---|
| Wellbutrin During ECT 1 | 2.60 |
| Wellbutrin During ECT 2 | 3.60 |
Duration of seizures with ECT. First measurement on day 1 of electroconvulsive treatment (ECT) and second measurement on day 2 of electroconvulsive therapy (ECT), separated by 1 day interval. This outcome measure was not measured at baseline. (NCT03126682)
Timeframe: Measured at day 1 and day 2
| Intervention | seconds (Mean) |
|---|---|
| Wellbutrin During ECT 1 | 26.2 |
| Wellbutrin During ECT 2 | 29.6 |
Charge in Millicoulombs at which subject gets a seizure with ECT. First measurement on day 1 of electroconvulsive treatment (ECT) and second measurement on day 2 of electroconvulsive therapy (ECT), separated by 1 day interval. This outcome measure was not measured at baseline. (NCT03126682)
Timeframe: Measured at day 1 and day 2
| Intervention | millicoulombs (Mean) |
|---|---|
| Wellbutrin During ECT 1 | 23.04 |
| Wellbutrin During ECT 2 | 19.68 |
14 trials available for lorazepam and Depression, Endogenous
| Article | Year |
|---|---|
Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Benzodiazepines; | 2004 |
Lormetazepam in depressive insomnia: new evidence of phase-response effects of benzodiazepines.
Topics: Administration, Oral; Adult; Aged; Cross-Over Studies; Depressive Disorder; Drug Administration Sche | 2004 |
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.
Topics: Adrenergic Uptake Inhibitors; Adult; Anti-Anxiety Agents; Antidepressive Agents; Celecoxib; Cyclooxy | 2006 |
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.
Topics: Adrenergic Uptake Inhibitors; Adult; Anti-Anxiety Agents; Antidepressive Agents; Celecoxib; Cyclooxy | 2006 |
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.
Topics: Adrenergic Uptake Inhibitors; Adult; Anti-Anxiety Agents; Antidepressive Agents; Celecoxib; Cyclooxy | 2006 |
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.
Topics: Adrenergic Uptake Inhibitors; Adult; Anti-Anxiety Agents; Antidepressive Agents; Celecoxib; Cyclooxy | 2006 |
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.
Topics: Adrenergic Uptake Inhibitors; Adult; Anti-Anxiety Agents; Antidepressive Agents; Celecoxib; Cyclooxy | 2006 |
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.
Topics: Adrenergic Uptake Inhibitors; Adult; Anti-Anxiety Agents; Antidepressive Agents; Celecoxib; Cyclooxy | 2006 |
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.
Topics: Adrenergic Uptake Inhibitors; Adult; Anti-Anxiety Agents; Antidepressive Agents; Celecoxib; Cyclooxy | 2006 |
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.
Topics: Adrenergic Uptake Inhibitors; Adult; Anti-Anxiety Agents; Antidepressive Agents; Celecoxib; Cyclooxy | 2006 |
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.
Topics: Adrenergic Uptake Inhibitors; Adult; Anti-Anxiety Agents; Antidepressive Agents; Celecoxib; Cyclooxy | 2006 |
[Comparison of bromazepam and lorazepam in the treatment of neurotic depression].
Topics: Adult; Anti-Anxiety Agents; Bromazepam; Clinical Trials as Topic; Depressive Disorder; Female; Human | 1980 |
A comparison of prazepam, diazepam, lorazepam and placebo in anxious outpatients in non-psychiatric private practices.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Depressive Disorder; Diazepam; Doub | 1981 |
Controlled comparison of milnacipran and fluoxetine in major depression.
Topics: Adult; Antidepressive Agents; Cyclopropanes; Depressive Disorder; Double-Blind Method; Female; Fluox | 1994 |
Hypnotics as concurrent medication in depression. A placebo-controlled, double-blind comparison of flunitrazepam and lormetazepam in patients with major depression, treated with a (tri)cyclic antidepressant.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Benzodiazepines; Depressive Disorder; | 1993 |
Catatonia: short-term response to lorazepam and dopaminergic metabolism.
Topics: Acute Disease; Adult; Anti-Anxiety Agents; Anxiety; Catatonia; Depressive Disorder; Dopamine; Dyskin | 1995 |
Lateralized neuropsychological functioning in depressive patients before and after drug therapy.
Topics: Adult; Aged; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzodiaz | 1996 |
Does lorazepam impair the antidepressant response to nortriptyline and psychotherapy?
Topics: Age Factors; Aged; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Combined Modality Therapy; | 1997 |
A multicentre double-blind comparative trial of fluvoxamine versus lorazepam in mixed anxiety and depression treated in general practice.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Anxiety Disorders; Depressive Disorder; Doubl | 1990 |
Pharmacologic provocation and dexamethasone suppression test sensitivity.
Topics: Caffeine; Depressive Disorder; Dexamethasone; Electroconvulsive Therapy; Humans; Hydrocortisone; Lor | 1989 |
The effects of acute scopolamine in geriatric depression.
Topics: Aged; Alzheimer Disease; Clinical Trials as Topic; Cognition; Depressive Disorder; Diagnosis, Differ | 1988 |
Viqualine in resistant depression: a double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Doubl | 1988 |
36 other studies available for lorazepam and Depression, Endogenous
| Article | Year |
|---|---|
Psychological Impact of the COVID-19 Pandemic Among the Elderly: A Case Series From India.
Topics: Acetamides; Aged; Aged, 80 and over; Anti-Anxiety Agents; Antidepressive Agents; Betacoronavirus; Ci | 2020 |
Exacerbation of mood symptoms associated to primary and secondary carnitine deficiency: a case report.
Topics: Adult; Antidepressive Agents; Antimanic Agents; Attention Deficit Disorder with Hyperactivity; Benzo | 2013 |
Drug trials in psychiatry: methodological issues.
Topics: Alcoholism; Chlordiazepoxide; Citalopram; Depressive Disorder; Diabetes Mellitus; Female; Humans; Hy | 2014 |
Recognition and treatment of serotonin syndrome.
Topics: Aged, 80 and over; Anticonvulsants; Depressive Disorder; Drug Interactions; Humans; Lorazepam; Male; | 2008 |
[Paroxetine-induced severe hyponatremic rhabdomyolisis].
Topics: Cations; Coma; Depressive Disorder; Diagnosis, Differential; Epilepsy, Tonic-Clonic; Female; Humans; | 2008 |
[Lamotrigine and the skin].
Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Depressive Disorder; Diagnosis, Differential; Disruptiv | 2010 |
Cases of catatonia on an academic electroconvulsive therapy service: lessons to learn.
Topics: Aged; Aged, 80 and over; Anxiety Disorders; Catatonia; Depressive Disorder; Depressive Disorder, Maj | 2011 |
An unusual presentation of catatonia in a patient with schizoaffective disorder.
Topics: Behavior; Catatonia; Depressive Disorder; Female; Fibrin Fibrinogen Degradation Products; Humans; Hy | 2011 |
A case of lorazepam (Ativan)-induced accommodation paresis.
Topics: Accommodation, Ocular; Depressive Disorder; Humans; Hypnotics and Sedatives; Lorazepam; Male; Paresi | 2012 |
Delayed onset and prolonged interictal delirium following electroconvulsive therapy.
Topics: Cholinesterase Inhibitors; Delirium; Depressive Disorder; Donepezil; Electroconvulsive Therapy; Foll | 2012 |
Musical hallucinations during a treatment with benzodiazepine.
Topics: Amitriptyline; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressive Disorder; Dose-Re | 2002 |
[Diphenhydramin-overdose: anticholinergic symptoms, EEG-findings in the course and drug treatment of a gerontopsychiatric patient].
Topics: Aged; Brain; Cholinergic Antagonists; Dementia; Depressive Disorder; Diphenhydramine; Drug Therapy, | 2004 |
Methylphenidate for alpha-interferon induced depression.
Topics: Affect; Aged; Antineoplastic Agents; Central Nervous System Stimulants; Depressive Disorder; Humans; | 2006 |
Neuroleptic malignant syndrome and aripiprazole.
Topics: Adolescent; Anti-Anxiety Agents; Antipsychotic Agents; Aripiprazole; Depressive Disorder; Female; Hu | 2006 |
Efficacy of imipramine in psychotic versus nonpsychotic depression.
Topics: Adult; Affective Disorders, Psychotic; Aged; Antidepressive Agents; Data Interpretation, Statistical | 2008 |
[Lorazepam. Evaluation after extensive use].
Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Bipolar Disorder; Depressive Disorder; Dogs; Humans | 1981 |
Lorazepam and desipramine serum concentration.
Topics: Aged; Anti-Anxiety Agents; Depressive Disorder; Desipramine; Drug Interactions; Female; Humans; Lora | 1982 |
The place of anxiety in depressive symptomatology.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Bipolar Disorder; Clorazepate Dipotas | 1983 |
Depression following withdrawal from long-term benzodiazepine use: a report of four cases.
Topics: Adult; Anti-Anxiety Agents; Depressive Disorder; Diazepam; Female; Flurazepam; Humans; Lorazepam; Ma | 1984 |
Lorazepam withdrawal and seizures.
Topics: Adolescent; Depressive Disorder; Female; Humans; Lorazepam; Seizures; Substance Withdrawal Syndrome | 1984 |
Clinical aspects of chronic use of alprazolam and lorazepam.
Topics: Alprazolam; Ambulatory Care; Anxiety Disorders; Depressive Disorder; Drug Administration Schedule; F | 1995 |
Exceptionally high seizure threshold: ECT device limitations.
Topics: Aged; Aged, 80 and over; Anti-Anxiety Agents; Bipolar Disorder; Depressive Disorder; Electroconvulsi | 1996 |
Catatonia due to mixed sedative withdrawal.
Topics: Adult; Catatonia; Depressive Disorder; Female; Humans; Lorazepam; Meprobamate; Substance Withdrawal | 1997 |
Treatment-refractory catatonia, ECT, and parenteral lorazepam.
Topics: Administration, Oral; Adult; Aged; Catatonia; Depressive Disorder; Drug Administration Schedule; Ele | 1999 |
[A possible interaction between josamycin and amitriptyline].
Topics: Adult; Amitriptyline; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Hum | 1992 |
Lorazepam, amitriptyline, and sulpiride: withdrawal effects.
Topics: Amitriptyline; Anxiety Disorders; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Lo | 1991 |
Electroconvulsive therapy in a patient with severe tic and major depressive episode.
Topics: Aged; Depressive Disorder; Electroconvulsive Therapy; Humans; Lorazepam; Male; Phenelzine; Pons; Psy | 1990 |
Depression in patients receiving lorazepam for panic.
Topics: Anxiety Disorders; Depressive Disorder; Fear; Humans; Lorazepam; Panic | 1989 |
Benzodiazepines for catatonic symptoms, stupor, and mutism.
Topics: Anti-Anxiety Agents; Benzodiazepines; Catatonia; Depressive Disorder; Diazepam; Female; Flumazenil; | 1988 |
Stupor and affective state: alleviation of psychomotor disturbances by lorazepam and recurrence of symptoms after Ro 15-1788.
Topics: Adult; Carbamazepine; Coma; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Femal | 1987 |
Delusional depression following benzodiazepine withdrawal.
Topics: Adult; Anxiety Disorders; Delusions; Depressive Disorder; Diazepam; Female; Humans; Lorazepam; Male; | 1988 |
Sublingual lorazepam use.
Topics: Administration, Oral; Adult; Amnesia; Depressive Disorder; Erectile Dysfunction; Humans; Lorazepam; | 1987 |
Treatment of catatonia with low-dose lorazepam.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Catatonia; Depressive Disorder; Female; Humans; L | 1987 |
Orofacial dyskinesias associated with lorazepam therapy.
Topics: Anxiety Disorders; Depressive Disorder; Dyskinesia, Drug-Induced; Facial Muscles; Female; Humans; Lo | 1986 |
[Temesta].
Topics: Aged; Anxiety; Depressive Disorder; Female; Humans; Lorazepam; Male; Pregnancy | 1985 |
Idiosyncratic pharmacokinetics complicating treatment of major depression in an elderly woman.
Topics: Depressive Disorder; Desipramine; Diphenhydramine; Female; Half-Life; Hospitalization; Humans; Kinet | 1985 |